Anitoa Systems is developing highly-integrated system-on-chip (SoC) products for a new generation of point-of-care diagnostics systems. Our current focus is a CMOS bio-molecular sensor chip and software to enable compact, field-portable nucleic-acid-test (NAT) platforms targeting infectious diseases. 

Our solution would allow doctors and physicians to obtain the diagnostic results at point-of-care in a matter of tens of minutes, instead of waiting for days and weeks to get the results from a centralized lab. Thus they can respond more quickly with life-saving treatments, such as targeted antibiotics; and slow the spread of drug-resistant bacteria and viruses.